Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123281) titled 'A Prospective, Randomized Controlled Clinical Trial of Finasteride Combined with Testosterone Undecanoate and Anastrozole in the Treatment of Benign Prostatic Hyperplasia' on April 23.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Affiliated Hospital of Zunyi Medical University
Condition:
Benign prostatic hyperplasia
Intervention:
Combination therapy group:Combination therapy with testosterone undecanoate, finasteride, and anastrozole
Recruitment Status: Recruiting
Phase: 2
Date of First Enrollment: 2025-11-18
Target Sample Size: Combination therapy group:107;Standard treatm...